CAUDAL REGRESSION SYNDROME side effect
What is CAUDAL REGRESSION SYNDROME ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
CAUDAL REGRESSION SYNDROME and Recently Reported Side Effects
CAUDAL REGRESSION SYNDROME and 15 most Active Side Effect polls
CAUDAL REGRESSION SYNDROME and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Rivotril Side Effects Report #5637375-1
Physician from FRANCE reported RIVOTRIL problem on Feb 11, 2008. Female patient, 24 years of age, was diagnosed with pain and was treated with RIVOTRIL. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, congenital bladder anomaly, . RIVOTRIL dosage: unknown. During the same period patient was treated with LYSANXIA, PAROXETINE, LEPTICUR, LARGACTIL, SULFARLEM, DAFALGAN, SUBUTEX. Patient recovered.
Novorapid Side Effects Report #5771743-2
NOVORAPID problem was reported by a Physician from CROATIA (local name: Hrvatska) on June 04, 2008. Male patient, weighting 9.26 lb, was diagnosed with type 1 diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, congenital absence of bile ducts, congenital genital malformation, faecal incontinence, fallot's tetralogy, hypospadias, patent ductus arteriosus, spina bifida, spleen malformation, . NOVORAPID dosage: unknown. During the same period patient was treated with LEVEMIR. Patient was hospitalized. Patient recovered.
Teveten Side Effects Report #5325811-X
Pharmacist from UNITED KINGDOM reported TEVETEN problem on Mar 30, 2007. Female patient was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, foetal disorder, hypoperfusion, premature baby, pulmonary hypoplasia, stillbirth, . TEVETEN dosage: 600 MG DAILY PO; A FEW WEEKS. During the same period patient was treated with METFORMIN, BENDROFLUAZIDE. Patient died on 10/22/2006.
Teveten Side Effects Report #5325812-1
TEVETEN problem was reported by a Pharmacist from UNITED KINGDOM on Mar 30, 2007. Female patient was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, foetal disorder, hypoperfusion, maternal condition affecting foetus, pulmonary hypoplasia, . TEVETEN dosage: 600 MG DAILY; A FEW WEEKS. During the same period patient was treated with METFORMIN, BENDROFLUAZIDE. Patient died on 10/22/2006.
Teveten Side Effects Report #5332860-4
Pharmacist from UNITED KINGDOM reported TEVETEN problem on Apr 25, 2007. Female patient, weighting 235.9 lb, was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, foetal disorder, hypoperfusion, pulmonary hypoplasia, stillbirth, . TEVETEN dosage: 600 MG DAILY PO. During the same period patient was treated with METFORMIN, BENDROFLUAZIDE. Patient died.
Teveten Side Effects Report #5332861-6
TEVETEN problem was reported by a Pharmacist from UNITED KINGDOM on Apr 25, 2007. Female patient was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, hypoperfusion, pulmonary hypoplasia, stillbirth, . TEVETEN dosage: 600 MG DAILY. During the same period patient was treated with METFORMIN, BENDROFLUAZIDE. Patient died on 10/22/2006.
Teveten Side Effects Report #5288303-2
Pharmacist from UNITED KINGDOM reported TEVETEN problem on Mar 15, 2007. Female patient was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, hypoperfusion, . TEVETEN dosage: 600 MG DAILY PO; A FEW WEEKS. During the same period patient was treated with METFORMIN, BENDROFLUAZIDE. Patient died.
Glucophage Side Effects Report #5694922-1
GLUCOPHAGE problem was reported by a Health Professional from GERMANY on Mar 25, 2008. Female patient, 37 years of age, was diagnosed with type 2 diabetes mellitus and was treated with GLUCOPHAGE. After drug was administered, patient experienced the following problems/side effects: abortion induced, amniotic fluid volume decreased, caudal regression syndrome, foetal growth retardation, pregnancy, . GLUCOPHAGE dosage: unknown. During the same period patient was treated with ACOMPLIA. Patient recovered.